Advanced Oncotherapy PLC (LSE:AVO) - Share price - Overview

Stock Report

Advanced Oncotherapy PLC AVO

Last Price
GBX41.50

Day Change
0.00|0.00%

As of 20/02/2019
17:08:10 GMT | GBX
Minimum 15 Minutes Delay.

Last Close41.50p
Day Range41.00 - 41.95
Mkt Cap80.74Mil
52-Wk Range33.00 - 64.00
Yield %-
ISINGB00BD6SX109
Volume51,344
P/E-2.36
P/SInfinity
P/CF-0.03

Share Price

Total Returns 19/02/2019

 Chg (%)  
More ...
Advanced Oncotherapy PLC7.79 
FTSE 100 TR GBP3.32
 
Financials
201520162017
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-7.62-13.09-14.49
Net Profit-5.85-10.37-13.66
Reported EPS-11.42-17.05-17.55
Balance Sheet
Current Assets16.6812.5412.50
Non Current Assets14.0625.1332.90
Total Assets30.7437.6745.40
Current Liabilities3.463.6816.74
Total Liabilities---
Total Equity27.2833.9928.66
Cash Flow
Operating Cash Flow-9.85-13.38-12.71
Net Change in Cash7.49-7.51-1.39
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
31/08/2018PurchaseDr Enrico Cipro Vanni49.00204,082100,000.00
31/08/2018PurchaseDr. Piers Nicholas Plowman49.00306,122150,000.00
31/08/2018PurchaseMr. Hans Henrik von Celsing49.0030,00014,700.00

Company Profile

Advanced Oncotherapy PLC is a medical care company which utilizes radiation-based treatment. Its technologies address serious illness in patients such as tumors.

Sector

Medical Devices

Index

FTSE AIM All-Share

Next Event 27/06/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-53.08
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr Enrico Cipro Vanni
Non-Executive DirectorMr. Michael Bradfield
Executive Director, Vice President, Global Business DevelopmentMr. Sanjeev Pandya
Executive Director, Chief Executive OfficerNicolas Serandour
Non-Executive DirectorProfessor Stephen Myers OBE
Non-Executive DirectorProfessor Christopher Nutting
Non-Executive DirectorDr. Piers Nicholas Plowman
Executive Director, ChairmanDr. Michael Jeffrey Sinclair
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.